Cargando…
A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells
BACKGROUND: Resistance to gefitinib remains a major obstacle for the successful treatment of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. In this paper, we studied the precise actions of circular RNA (circRNA) microtubule actin crosslinking factor 1 (cir...
Autores principales: | Fan, Daping, Yang, Yue, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742390/ https://www.ncbi.nlm.nih.gov/pubmed/34996416 http://dx.doi.org/10.1186/s12890-021-01731-z |
Ejemplares similares
-
Circ_MACF1 targets miR‐421 to upregulate FMO2 to suppress paclitaxel resistance and malignant cellular behaviors in lung adenocarcinoma
por: Qian, Xiaoting, et al.
Publicado: (2023) -
CircMACF1 alleviates myocardial fibrosis after acute myocardial infarction by suppressing cardiac fibroblast activation via the miR-16-5p/SMAD7 axis
por: Wang, Yonghong, et al.
Publicado: (2023) -
Circ_0102543 suppresses hepatocellular carcinoma progression through the miR‐942‐5p/SGTB axis
por: Yang, Shiming, et al.
Publicado: (2023) -
Circ_0005927 Inhibits the Progression of Colorectal Cancer by Regulating miR-942-5p/BATF2 Axis
por: Yu, Chao, et al.
Publicado: (2021) -
CircPTK2 inhibits cell cisplatin (CDDP) resistance by targeting miR-942/TRIM16 axis in non-small cell lung cancer (NSCLC)
por: Wang, Yongfu, et al.
Publicado: (2022)